MDCX Stock Analysis: Buy, Sell, or Hold?
MDCX - Medicus Pharma Ltd. Common Stock
$0.46
0.01 (1.34%)
▲
5d:
+42.19%
30d:
+59.09%
90d:
-9.0%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: MDCX is 16.7% above its trading range ($0.39). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: MDCX is 16.7% above its trading range ($0.39). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $0.46, which is considered extended relative to its 30-day fair value range of $0.29 to $0.39.
Technical Outlook: Technically, MDCX is in a strong downtrend. The price is approaching resistance at $0.40. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MDCX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.67 (+1145.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDCX is in a strong downtrend. The price is approaching resistance at $0.40. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MDCX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.67 (+1145.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.29 -
$0.39
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+16.7% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1145.4% below Wall St target ($5.67)
- WARNING: Recommendation downgraded due to 16.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.29 -
$0.39
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.29
Resistance Level
$0.40
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.17
Wall Street Target
$5.67
(+1145.4%)
Share & Embed Analysis
Last updated: June 24, 2026 8:33 AM ET
Data refreshes hourly during market hours. Next update: 9:33 AM
Data refreshes hourly during market hours. Next update: 9:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1219 | 52 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 56 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$254 | 66 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$353 | 64 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$220 | 63 BUY |
